Introduction
============

The *uvrB* gene encodes the UvrB protein, one of the key components of the NER system ([@B50]). NER repair is a versatile pathway that recognizes a wide range of DNA lesions by the concerted function of the UvrABC proteins ([@B37]). The *uvrB* gene belongs to the SOS regulon ([@B19]). SOS is a global response to DNA damage in which RecA filaments bound on ssDNA promote self-cleavage of the LexA protein. Cleavage of LexA induces expression of the SOS genes, resulting in an arrest of cell division for the time required to repair the damages ([@B55]). LexA regulates the SOS regulon by binding to the LexA-box and thus preventing gene expression during normal growth. The LexA-box has the following consensus sequence TACTG(TA)~5~CAGTA ([@B54]), having a conserved trimer of CTG on the left and another trimer of CAG on the right with a variable sequence of spacers; the spacing between "CTG" and "CAG" is invariable at 10 nucleotides ([@B14]; [@B53]). LexA contains two domains: an N-terminal winged helix-turn-helix (wHTH) DNA-binding domain and a C-terminal dimer with a latent protease domain ([@B56]). In response to DNA damage RecA-ssDNA-ATP filaments are formed and the auto-proteolytic activity of LexA at the C-terminal domain is activated by interacting with the filaments. The degradation of LexA opens the promoter region for RNA polymerase (RNAP) recruitment and the start of transcription.

The DnaA protein initiates chromosomal replication in bacteria by interacting with 9-mer consensus sequences of TTA/TTNCACA, the DnaA-boxes, at the origin for replication ([@B21]; [@B44]). DnaA has a high affinity for ATP and ADP ([@B45]), and ATP-DnaA is active for the initiation of replication whereas ADP-DnaA is inactive ([@B45]). DnaA is also a transcription factor, repressing transcription by binding to DnaA-boxes in the promoter regions, such as those found at the promoters for the *dnaA* gene itself ([@B2]; [@B6]), the *mioC* gene ([@B26]) and the *nrd* operon ([@B51]; [@B48]; [@B35]) while transcription of the *polA* gene is stimulated by DnaA in stationary phase ([@B39]).

The *E. coli uvrB* promoter region contains three promoters, namely, *uvrB*p1, *uvrB*p2, and *uvrB*p3 ([@B43]). A LexA-box with the AACTGTTTTTTTATCCAGTA sequence has been identified between the -35 and -10 regions of *uvrB*p2 ([@B14]). Interestingly, the *uvrB*p3 promoter contains DnaA boxes ([@B1]) which constitute the DARS1 (DnaA reactivation site) site consisting of three DnaA-boxes, where inactive ADP-DnaA is reactivated to form active ATP-DnaA ([@B16]). Here, we show that the *uvrB* promoters are repressed by both DnaA and LexA by specifically binding to its promoter region in either a competitive or an independent manner. Interestingly, two other genes of the SOS regulon, *recN* and *dinJ*, are also found to be repressed by both DnaA and LexA. The simultaneous absence of LexA- and DnaA-dependent repression leads to production of elongated cells with incomplete DNA replication with abnormal nucleoids and slow growth. It is likely that regulation of gene expression by DnaA maintains genome integrity during the SOS response in *Escherichia coli.*

Materials and Methods {#s1}
=====================

Bacterial Strains
-----------------

All bacterial strains used in this study are derived from the *E. coli* K12 listed in **Table [1](#T1){ref-type="table"}**. The Δ*sulA*::*neo* allele was transferred into the MC4100 by P1 transduction ([@B31]) and resulting in MC4100Δ*sulA*::*neo*. The *cat* gene was PCR amplified using the plasmid pKD3 as template and primer 582 and 583 as listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"} and inserted into MC4100Δ*sulA*::*neo* mutant to replace the chromosomal *lexA* gene through homologous recombination by One-step Chromosomal Gene Inactivation method ([@B11]), resulting in MC4100Δ*sulA*::*neo*Δ*lexA*::*cat* double mutant. The *neo* or/and *cat* genes were removed by the FRT site-specific recombination as described previously ([@B11]), resulting in MC4100Δ*sulA* or/and MC4100Δ*sulA*Δ*lexA* double mutant. The *cat* gene was also PCR amplified using pKD3 as template and primers 48 and 49 listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}, then inserted behind the chromosomal *uvrB* gene in MC4100 and MC4100Δ*sulA*Δ*lexA* cells by the method mentioned above. The *cat* gene was replaced by pCE36 using the FRT site-specific recombination in the cells mentioned, resulting in insertion of the *lacZ*...*neo* fusion behind the chromosomal *uvrB* gene as described previously ([@B11]; [@B12]). As a result, MC4100*uvrB-lacZ*...*neo*, MC4100Δ*sulA uvrB-lacZ*...*neo* and MC4100Δ*sulA*Δ*lexA uvrB-lacZ*...*neo* cells were constructed. The *dnaA*~A345S~...*cat* allele was transferred into the MC4100*uvrB-lacZ*...*neo*, MC4100Δ*sulA uvrB-lacZ*...*neo* and MC4100Δ*sulA*Δ*lexA uvrB-lacZ*...*neo* cells by P1 transduction ([@B31]). The *lexA*3...*tet* allele was P1 transduced into MC4100 and *dnaA*~A345S~...*cat* cells carrying *uvrB-lacZ*...*neo* fusion, respectively ([@B31]). For construction of *recN*-*lacZ*...*neo* and *dinJ*-*lacZ*...*neo*, the *cat* gene was PCR amplified using the plasmid pKD3 as template and primers 1229 and 1230 for *recN*-*lacZ*...*neo*, primers 1235 and 1236 for *dinJ*-*lacZ*...*neo* as listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}. After insertion of the *cat* gene down-stream of the chromosomal *recN or dinJ* gene in MC4100 cells, the *cat* gene was replaced by pCE36 using the FRT site-specific recombination, resulting in insertion of the *lacZ*...*neo* fusion behind the chromosomal *recN or dinJ* gene as described previously ([@B11]; [@B12]). The *recN*-*lacZ*...*neo or dinJ*-*lacZ*...*neo* allele was P1 transduced into *dnaA*~A345S~, Δ*sulA*Δ*lexA*, Δ*sulA*Δ*lexA dnaA*~A345S~ and *lexA*3 *dnaA*~A345S~ cells, resulting in *dnaA*~A345S~ *recN-lacZ*...*neo*, Δ*sulA*Δ*lexA recN-lacZ*...*neo*, Δ*sulA*Δ*lexA dnaA*~A345S~ *recN-lacZ*...*neo*, *lexA*3 *dnaA*~A345S~ *recN-lacZ*...*neo*, or *dnaA*~A345S~ *dinJ-lacZ*...*neo*, Δ*sulA*Δ*lexA dinJ-lacZ*...*neo*, Δ*sulA*Δ*lexA dnaA*~A345S~ *dinJ-lacZ*...*neo* and *lexA*3 *dnaA*~A345S~ *dinJ-lacZ*...*neo*. DH5α was used as a host for the preparation of plasmid DNA. The WM2287 strain containing the p*dnaA*116 plasmid was used for DnaA purification ([@B44]) and BL21-Gold (DE3) for His~6~-LexA protein expression and purification.

###### 

Bacterial strains.

  Strain            Genotype                                                                               Source
  ----------------- -------------------------------------------------------------------------------------- ----------------------
  MC4100            Wild type F^-^*araD*139Δ (*lac*) U169 *strA thi*                                       [@B8]; [@B13]
  BW25113           Wild type *rrnB*3 Δ*lacZ*4787 *hsdR*514 Δ(*araBAD*)567Δ (*rhaBAD*)568 *rph-1*          [@B3]
  JW0941-KC         BW25113Δ *sulA*::*neo*                                                                 [@B3]
  SMG379            MG1655 *dnaA*~A345S~...MiniTn10 *cat*                                                  [@B18]
  JC13199           *lexA3malE\...*Tn10                                                                    [@B10]
  MOR741            MC4100 *uvrB-lacZ*...*neo*                                                             This work
  MOR746            MC4100 *dnaA* ~A345S~...*cat uvrB-lacZ*...*neo*                                        This work
  MOR2395           MC4100 Δ*sulA*Δ*lexA uvrB*-*lacZ*... *neo*                                             This work
  MOR2399           MC4100 Δ*sulA* Δ*lexA dnaA*~A345S~...*cat uvrB-lacZ*...*neo*                           This work
  MOR2670           MC4100 Δ*sulA*::*neo*                                                                  This work
  MOR2672           MC4100 Δ*sulA uvrB*-*lacZ*... *neo*                                                    This work
  MOR798            MC4100 *lexA*3...*tet uvrB-lacZ*...*neo*                                               This work
  MOR803            MC4100 *lexA*3... *tet dnaA* ~A345S~...*cat uvrB-lacZ*...*neo*                         This work
  MOR749            MC4100 *dnaA* ~A345S~...*cat*                                                          This work
  MOR1466           MC4100 Δ*sulA*Δ*lexA*                                                                  This work
  MOR1511           MC4100 Δ*sulA*Δ*lexA dnaA*~A345S~...*cat*                                              This work
  MOR2585           MC4100 *recN-lacZ*...*neo*                                                             This work
  MOR2586           MC4100 *dnaA* ~A345S~...*cat recN-lacZ*...*neo*                                        This work
  MOR2587           MC4100 Δ*sulA*Δ*lexA recN*-*lacZ*... *neo*                                             This work
  MOR2588           MC4100 Δ*sulA* Δ*lexA dnaA*~A345S~...*cat recN-lacZ*...*neo*                           This work
  MOR2589           MC4100 *lexA*3...*tet dnaA*~A345S~...*cat recN-lacZ*...*neo*                           This work
  MOR2590           MC4100 *dinJ-lacZ*...*neo*                                                             This work
  MOR2591           MC4100 *dnaA* ~A345S~...*cat dinJ-lacZ*...*neo*                                        This work
  MOR2592           MC4100 Δ*sulA*Δ*lexA dinJ*-*lacZ*... *neo*                                             This work
  MOR2593           MC4100 Δ*sulA* Δ*lexA dnaA*~A345S~...*cat dinJ-lacZ*...*neo*                           This work
  MOR2594           MC4100 *lexA*3...*tet dnaA*~A345S~...*cat dinJ-lacZ*...*neo*                           This work
  BL21-Gold (DE3)   *E. coli* B F^-^*ompT hsdS*B (r~B~^-^m~B~^-^) *dcm^+^* Tet^r^ *gal* (DE3) *endA* Hte   Agilent Technologies
  DH5α              F^-^ *sup*E44 *Δlac*U169(*ΔlacZΔM15*) *hsdR*17 *recA*1 *endA*1 *gyrA*96                New England Biolabs

Growth Media and Conditions
---------------------------

Cells were grown at 37°C in LB ([@B4]) or ABTGcasa medium ([@B34]). When necessary, 100 μg/ml of ampicillin, 30 μg/ml of chloramphenicol, 15 μg/ml of tetracycline and 50 μg/ml of kanamycin were added.

Plasmid Constructions
---------------------

All plasmids used in this study are listed in **Table [2](#T2){ref-type="table"}** and the primers including their descriptions are listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}. The *uvrB*p1-3 promoter was PCR amplified using chromosomal DNA from the wild-type BW25113 cells as template and primers 54 and 57. The *uvrB*p1-3 PCR fragment was inserted in front of the promoterless *lacZ* gene on pTAC3953 ([@B7]) at *Bam*HI and *Hin*dIII sites, resulting in plasmid p*uvrB*p1-3-*lacZ*. Using the same template, the *uvrB*p1-2 promoter region was amplified by primers 79 and 57, and the *uvrB*p3 promoter region by primers 54 and 71. The PCR fragment for each promoter was then inserted into pTAC3953 at the *Bam*HI and *Hin*dIII sites ([@B7]), leading to the construction of plasmids p*uvrB*p1-2-*lacZ* and p*uvrB*p3-*lacZ*. The *uvrB*p1-3-*lacZ* fusion was PCR amplified by primers 54 and 1131 using p*uvrB*p1-3-*lacZ* as template. The PCR fragment was then inserted into a low copy plasmid, MiniR1 which is about 1--2 copies per the chromosomal *ter* site ([@B32]) at the *Bam*HI and *Hin*dIII sites, resulting in MiniR1-*uvrB*p1-3-*lacZ* (shown as R1-*uvrB*p1-3 for short). The *uvrB*p1-2-*lacZ* fusion was PCR amplified by primers 79 and 1350 using p*uvrB*p1-2-*lacZ* as template. The PCR fragment was then inserted into MiniR1 at the *Bam*HI and *Bgl*II sites, resulting in MiniR1-*uvrB*p1-2-*lacZ* (R1-*uvrB*p1-2 for short). The *uvrB*p3-*lacZ* fusion was PCR amplified by primers 54 and 1350 using p*uvrB*p3-*lacZ* as a template. The PCR fragment was inserted into MiniR1 at *Bam*HI and *Bgl*II sites, resulting in MiniR1-*uvrB*p3-*lacZ* (R1-*uvrB*p3 for short). The DH5α cells were transformed with the resulting ligation. The *lexA* gene was PCR amplified using the chromosomal DNA from the wild-type BW25113 cells as template and primers 578 and 579. The PCR fragment for *lexA* was inserted into pET28a (EMD Biosciences) at the *Nco*I and *Xho*I sites, resulting in pET28a-his~6~-*lexA* which produces His~6~-LexA protein fusion under IPTG induction. All constructions were sequenced to make sure the plasmid constructions were correct.

###### 

Plasmids.

  Plasmids                   Description                                                                                                                                                       Source
  -------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------
  pKD3                       *rep*~R6K~ *bla* FRT *cat* FRT                                                                                                                                    [@B11]
  pKD4                       *rep*~R6K~ *bla* FRT *neo* FRT                                                                                                                                    [@B11]
  pKD46                      *rep*~pSC101~^ts^*bla* P~araBAD~ γβ exo                                                                                                                           [@B11]
  pCP20                      *rep*~pSC101~^ts^ *bla cat cI*857P~R~                                                                                                                             [@B11]
  pCE36                      *rep*~R6K~ *neo* FRT *lacZY* t*~his~*                                                                                                                             [@B12]
  pET-28a                    *rep*~ColE1~ *neo lacI* P~T7~                                                                                                                                     EMD Biosciences
  pET28a-his~6~-*lexA*       The *lexA* gene was inserted into pET28a at *Nco*I and *Xho*I to produce His~6~-LexA fusion.                                                                      This work
  p*dnaA*116                 *rep*~ColE1~ *bla lacI^+^*P~A1-03/04~ *dnaA ter~trpA~*                                                                                                            [@B22]
  pTAC3953                   *rep*~Pmd~ *neo lacZ*                                                                                                                                             [@B7]
  p*uvrB*p1-3-*lacZ*         The whole cluster of the *uvrB* promoters including *uvrB*p1, 2, and 3 was inserted in front of the *lacZ* gene on pTAC3953 at the *Bam*HI and *Hin*dIII sites.   This work
  p*uvrB*p1-2-*lacZ*         The *uvrB*p1-2 fragment was inserted in front of the *lacZ* gene on pTAC3953 at the *Bam*HI and *Hin*dIII sites.                                                  This work
  p*uvrB*p3-*lacZ*           The *uvrB*p3 fragment was inserted in front of the *lacZ* gene on pTAC3953 at the *Bam*HI and *Hin*dIII sites.                                                    This work
  p*uvrB*pΔ279-172-*lacZ*    A fragment from -279 to -172 was deleted from the plasmid p*uvrB*p1-3-*lacZ.*                                                                                     This work
  MiniR1                     R1 derived vector, containing *oriR*1, *bla*, *repA*, *tap*, *copA*                                                                                               [@B32]
  MiniR1-*uvrB*p1-3-*lacZ*   The *uvrB*p1-3-*lacZ* fusion fragment was inserted at the *Bam*HI and *Hin*dIII sites onto MiniR1.                                                                This work
  MiniR1-*uvrB*p1-2-*lacZ*   The *uvrB*p1-2-*lacZ* fragment was inserted at the *Bam*HI and *Bgl*II sites onto MiniR1.                                                                         This work
  MiniR1-*uvrB*p3-*lacZ*     The *uvrB*p3-*lacZ* fragment was inserted at the *Bam*HI and *Bgl*II sites onto MiniR1.                                                                           This work
  p*uvrB*p1-2GC-*lacZ*       TG in LexA-box1 was replaced by GC on p*uvrB*p1-2-*lacZ.*                                                                                                         This work
  p*uvrB*p3CA-*lacZ*         TG in DnaA-box6 was replaced by CA on p*uvrB*p3-*lacZ.*                                                                                                           This work

Site-Directed Mutagenesis
-------------------------

Point mutation was generated using a site-directed mutagenesis kit (TransGen Biotech, Beijing, China) as described previously ([@B40]). The mutations (from TG to GC) in LexA-box1 in the *uvrB*p1-2 promoter were generated by site-directed mutagenesis using the p*uvrB*p1-2-*lacZ* plasmid as template and the pair of primers 1214 and 1215. Similarly, using the p*uvrB*p3 plasmid as template, the mutations (from TG to CA) in DnaA-box6 in *uvrB*p3 promoter, were generated by the pair of primers 1210 and 1211.

Purification of Proteins
------------------------

The DnaA protein was over-expressed in WM2287/p*dnaA*116 cells ([@B22]) and purified as described previously ([@B35]). The BL21-Gold (DE3)/pET28a-his~6~-*lexA* cells were grown at 37°C in 200 ml of LB medium. At OD~600~ = 0.6, IPTG with 0.3 mM of final concentration was added and incubated for 2 h. The cells were harvested and washed with PBS once, resuspended in 10 ml of the lysis buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 10 mM imidazole), and sonicated. The whole cell lysate was mixed with His-Select Ni-NTA slurry (Qiagen) and His~6~-LexA was purified according to the manufacturer instructions. Purity of the His~6~-LexA protein sample was detected by staining with INSTANT BLUE (Expedeon) after SDS-PAGE (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}) gel-electrophoresis following the manufacturer instructions. The His~6~-LexA protein concentration was determined by BCA assay (Thermo Scientific) and stored at -80°C after imidazole was removed by dialysis in 1xPBS buffer (0.137 M NaCl, 0.027 M KCl, 0.01 M Na~2~HPO~4~, 0.0018 M KH~2~PO~4~).

β-Galactosidase Activity Assay
------------------------------

Exponentially growing cells (1 ml) at 37°C in ABTGcasa medium were collected at OD~450~ = 0.1, 0.2, 0.3, 0.4, and 0.5, then mixed with cold toluene (0.1 ml) and kept on ice immediately. For measurement of β-galactosidase activity, 0.2 ml toluene-treated sample was added to 1 ml Z buffer (40 mM NaH~2~PO~4~, 60 mM Na~2~HPO~4~, 10 mM KCl, 1 mM MgSO~4~ and 50 mM β-mercaptoethanol, pH 7.0) containing 0.66 mg/ml *o*-nitrophenyl-β-[D]{.smallcaps}-galactopyranoside. The reaction was performed at 30°C until the color changed to yellow and stopped by addition of 0.5 ml 1 M Na~2~CO~3~, and the absorbance at OD~420~ was measured. The β-galactosidase activity was calculated by 1000^∗^OD~420~/reaction time (min) ^∗^OD~450~^∗^0.2 ml ([@B30]).

DNase I Footprinting Assays
---------------------------

The *uvrB* promoter region (523bp) was PCR amplified using chromosomal DNA from the wild-type BW25113 cells as template and primer 828 and 829 for the DNase I footprinting assays. In the PCR reaction, the primer 828 was 5′ labeled with \[γ-^32^P\] ATP (GE Healthcare) by T4 polynucleotide kinase (New England Biolabs). The PCR product was purified with the Bio-Spin 6 Columns (Bio-Rad) according to the manufacturer instructions. Approximately 1 nmol of labeled DNA and increasing amounts (final concentration was 50, 100, 200, 300, and 600 nM) of ATP-DnaA or His~6~-LexA protein were mixed in a 10 μl reaction buffer containing 1 mM DTT, 0.5 mg/ml Ac-BSA, 20 mM HEPES pH 7.6, 50 mM *K*-glu, 5 mM MgCl~2~ and 3 mM of ATP (Sigma-Aldrich). The reaction mixture was incubated at 37°C for 15 min. Then, 4 mg/ml of DNase I diluted in digestion buffer (25 mM Tris pH 7.5, mM MgCl~2~, 1 mM CaCl~2~, 2 mM DTT and 100 mM KCl) was added and the mixture was incubated at 37°C for 20 s. To determine the protection patterns of the *uvrB* promoter DNA by two proteins (DnaA and LexA), the second protein was added with final concentrations of 50, 100, 200, 300, and 600 nM after 10 min incubation with the first protein with final concentration of 200 nM, and incubated for 10 min, then digested by DNase I for 30 s. The DNase I digestion was stopped by addition of an equal volume of formamide loading buffer (90% formamide, 1 × TBE, bromophenol blue, xylene cyanol, calf thymus non-specific DNA). Samples were incubated for 5 min at 95°C and analyzed by 6% acrylamide in denaturing conditions (8 M urea and 1 × TBE buffer) by comparison with a DNA sequence ladder generated with the same primers using a A+G reaction as described previously ([@B29]). After electrophoresis, gels were dried and autoradiographed.

UV Irradiation
--------------

Cells were exponentially grown at 37°C in 50 ml of ABTGcasa medium, 20 ml of cell culture at OD~450~ = 0.08 was irradiated in an open petri-dish with 50 J/M^2^ of UV, then cells were grown in flask at 37°C. Sampling and measurement of β-galactosidase activity was carried out as mentioned above.

Flow Cytometry
--------------

Exponentially growing cells in ABTGcasa medium at 37°C were treated with 300 μg/ml rifampicin and 10 μg/ml cephalexin for 4--5 generations. Initiation of DNA replication is inhibited by rifampicin which allows ongoing replication finish while cell division is blocked by cephalexin at the time of addition of the drugs ([@B47]; [@B5]). Cells were fixed in 70% ethanol and stained in Hoechst 33258 (Invitrogen) for 30 min, then analyzed by flow cytometry (LSR Fortessa, BD).

Confocal Fluorescence Microscopy
--------------------------------

Exponentially growing cells in ABTGcasa medium at 37°C were harvested, fixed in 70% ethanol, visualized under a Zeiss LSM710 Confocal microscope with 100×/1.4 Plam-Apo at 405 nm laser excitation after staining in Hoechst 33258 for 30 min. Images were scanned by a PMP detector and analyzed with the ZEN 2011 (black version) software to measure cell size and nucleoid distribution.

Results
=======

Both DnaA and LexA Repress Expression of the *uvrB* Gene
--------------------------------------------------------

A global transcriptional analysis by using Affymetrix GeneChip *E. coli* Genome 2.0 arrays showed that expression of the *uvrB* gene increased 2.7 (±0.9)-fold in a *dnaA*~A345S~ mutant relative to the wild-type cells (Morigen and Skarstad, unpublished data). The result suggests that DnaA could directly be involved in control of the *uvrB* gene expression since DnaA~A345S~ binds to DnaA-boxes with a lower affinity compared to wild-type DnaA. The *dnaA*~A345S~ mutant is a suppressor for a mutant lacking four of the redoxins involved in Nrd activity ([@B36]) and the purified DnaA~A345S~ protein is defective for ATP binding *in vitro* ([@B18]). The *dnaA*~A345S~ mutant is also found to result in under-replication and larger cell mass with slower growth ([@B36]; [@B18]). In order to determine the regulatory effect of DnaA on transcription of the *uvrB* gene, the *lacZ* reporter gene was inserted downstream of the chromosomal *uvrB* gene, resulting in an *uvrB-lacZ* derivative of the MC4100 strain lacking the chromosomal *lacZ* gene ([@B8]; [@B13]). Subsequently, a *dnaA*~A345S~ allele was transferred to the *uvrB-lacZ* strain by P1 transduction. The *uvrB* gene belongs to the SOS regulon which is regulated by LexA ([@B19]). It should be noted that the LexA protein is essential for cell growth but the growth defect in the absence of LexA can be suppressed by deletion of the *sulA* gene ([@B17]). Thus, we removed the *lexA* gene by constructing the Δ*lexA* Δ*sulA* double mutant. To understand how DnaA interacts with LexA in the control of *uvrB* expression, the *uvrB-lacZ* allele was P1 transduced into the Δ*lexA* Δ*sulA*, Δ*lexA* Δ*sulA dnaA*~A345S~, *lexA3* and *lexA3 dnaA*~A345S~ cells including the Δ*sulA* mutant as a control. The level of transcription from the *uvrB* promoter region was measured by the β-galactosidase activity assay in exponentially growing cells. Transcription from the *uvrB* promoter was 3.5-fold higher in the *dnaA*~A345S~ cells compared with that of the wild-type cells (**Figure [1A](#F1){ref-type="fig"}**), suggesting that DnaA represses *uvrB* expression. Not surprisingly, transcription from the *uvrB* promoter region in the Δ*sulA* mutant was about the same as that in the wild-type cells, while it was 3.3-fold higher in the Δ*lexA*Δ*sulA* mutant compared to the control, in agreement with previous work ([@B43]), indicating that LexA represses *uvrB* expression. Interestingly, *uvrB* transcription was further increased, to 5.2-fold, in the Δ*lexA*Δ*sulA dnaA*~A345S~ triple mutant (**Figure [1A](#F1){ref-type="fig"}**), implying that the repression by DnaA and LexA of *uvrB* expression is additive and thus might be independent of an interaction between the two proteins. The conclusion is supported by 1.6-fold increase of *uvrB* expression in the Δ*sulA*Δ*lexA dnaA*~A345S~ cells compared to that in the Δ*sulA*Δ*lexA* cells (**Figure [1A](#F1){ref-type="fig"}** inset). The LexA3 mutant protein is not self-cleavable or largely resistant to cleavage and thus binds to the *uvrB* promoter region regardless of whether the SOS response is on or off ([@B25]; [@B28]). Transcription from the *uvrB* promoter region in the *lexA*3 mutant was about the same as that in the wild-type cells, while it was 3.6-fold higher in the *lexA*3 *dnaA*~A345S~ strain (**Figure [1B](#F1){ref-type="fig"}**). These results support the idea that DnaA-dependent repression of *uvrB* expression is independent of LexA activity. We conclude that in the absence of the SOS response both DnaA and LexA repress transcription of the *uvrB* gene and function independently of each other.

![The DnaA and LexA proteins repress expression of the *uvrB* gene independently. **(A)** The wild-type, Δ*sulA, dnaA*~A345S~, Δ*sulA*Δ*lexA* and Δ*sulA*Δ*lexA dnaA*~A345S~ cells carrying *uvrB*-*lacZ* fusion on their chromosomes were exponentially grown in ABTGcasa medium at 37°C. The β-galactosidase activity from *uvrB*-*lacZ* fusion in the cells was determined by Miller method ([@B30]), and relative expressions of *uvrB-lacZ* in all mutants to that in the wild-type (14 U) were calculated. The inset indicates the relative expression of *uvrB-lacZ* in the Δ*sulA*Δ*lexA dnaA*~A345S~ cells against that in the Δ*sulA*Δ*lexA* cells. **(B)** The β-galactosidase activity in exponentially growing *lexA*3 and *lexA*3*dnaA*~A345S~ cells carrying *uvrB*-*lacZ* fusion was determined as described in the legend to **(A)**. The inset indicates the relative expression of *uvrB-lacZ* in the *lexA*3*dnaA*~A345S~ cells against that in the *lexA*3 cells. The values shown at top of the bars are the average of three individual experiments, and the standard errors are shown. ^∗∗∗^Stands for *P*-value ≤ 0.01, ^∗∗^for 0.01 \< *P*-value ≤ 0.05, and ns represents *P*-value \> 0.05.](fmicb-09-01212-g001){#F1}

The *uvrB* Promoter Region Contains Seven Potential DnaA-Boxes and Four LexA-Boxes
----------------------------------------------------------------------------------

In order to understand how LexA and DnaA function in the control of *uvrB* transcription, we searched for the sequences corresponding to DnaA-boxes and LexA-boxes in the *uvrB* promoter region. The *uvrB* promoter region was previously shown to contain three DnaA-boxes ([@B16]) and one LexA-box ([@B52]). By our analysis, four additional DnaA-boxes and three potential LexA-boxes were identified in the region (**Figure [2](#F2){ref-type="fig"}**). All these DnaA-boxes were renamed as DnaA-box1, 2, 3, 4, 5, 6, and 7 from the proximal to the distal site relative to the transcription start site of the *uvrB*p1 promoter (**Figure [4A](#F4){ref-type="fig"}**). The characterized LexA-boxes were called LexA-box1, 2, 3, and 4, also in the same orientation (**Figure [2](#F2){ref-type="fig"}**). LexA-box1 is closest to the consensus, having the conserved CTG trimer on the left and the CAG trimer on the right end, with nine ATs out of ten bases between these two trimers. LexA-box2, 3, and 4, however, have a CTG on the left but do not have CAG on the right end, having an AT-rich sequence in the middle. LexA-box1 is located between the -35 and -10 sites of the *uvrB*p2 promoter (**Figure [4A](#F4){ref-type="fig"}**) ([@B43]), overlapping with DnaA-box1. LexA-box2 and 3 are found between the *uvrB*p2 and *uvrB*p3 promoters (**Figure [4A](#F4){ref-type="fig"}**), and LexA-box4 is found within the DARS1 ([@B16]), overlapping with DnaA-box5 and 6 on the *uvrB*p3 promoter (**Figures [2](#F2){ref-type="fig"}**, **[4A](#F4){ref-type="fig"}**). DnaA-box2, 3 and 4 are located between *uvrB*p2 and *uvrB*p3, and three other DnaA-boxes (DnaA-box5, 6, and 7) are found in the *uvrB*p3 promoter (**Figure [2](#F2){ref-type="fig"}**), composing the DARS1 region ([@B16]). The presence of DnaA-boxes in the *uvrB* promoter region support the idea that DnaA might be directly involved in transcription control of the *uvrB* gene and also suggest a possible cooperative or competitive interaction with LexA via their overlapping binding sites ([@B52]).

![The *uvrB* promoter cluster contains three promoters, seven potential DnaA-boxes and four LexA-boxes. Seven potential DnaA binding sites (DnaA-box1, 2, 3, 4, 5, 6, and 7) in the *uvrB* promoter region are boxed and labeled. DARS1 site consists of DnaA-box 5, 6, and 7. The stars represent the mismatched nucleotides to the consensus DnaA-box (TTA/TTNCACA). The potential LexA-boxes are boxed with a dashed line and labeled. The --35 and --10 sites of the promoters are underlined and labeled. The positions of nucleotides at the transcriptional starting site from promoter *uvrB*p1, p2 and p3 are indicated by p1, p2 and p3 with arrow, respectively, while p1 is numbered as +1 ([@B43]; [@B1]). The letters in bold indicate the transcriptional starting sites (+1) from different promoters.](fmicb-09-01212-g002){#F2}

DnaA Interferes With Binding of LexA to LexA-Box2 and 3 but Not to LexA-Box1
----------------------------------------------------------------------------

As described above, we have shown that both DnaA and LexA repress transcription from the *uvrB* promoter cluster, which contains seven potential DnaA-boxes and four LexA-boxes. Now the questions are: (i) do DnaA and/or LexA bind to these potential DnaA-boxes and/or LexA-boxes? (ii) do DnaA and LexA compete for their binding sites in the *uvrB* promoter region? To address these questions, we performed *in vitro* DNase I footprinting experiments and determined the binding patterns of DnaA and LexA to the *uvrB* promoter cluster. A PCR amplified fragment (523 bp) of the *uvrB* promoter cluster was used in these experiments. The DnaA protein was purified as described previously ([@B35]) and His~6~-LexA was purified as described in Materials and Methods (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). A protection pattern of the *uvrB* promoter cluster by increasing concentrations of LexA was detected in the presence or absence of DnaA. As shown in **Figure [3](#F3){ref-type="fig"}**, LexA protections of LexA-box2, 3, and 4 increased as a function of its concentration whereas LexA-box1 became protected at the lowest concentration of LexA. These results are in agreement with the differences in the LexA-box2, 3, and 4 sequences relative to the consensus sequence of LexA-box1. In the presence of DnaA, the LexA protections to LexA-box2, 3, and 4 were weakened or abolished in a DnaA concentration dependent manner while binding to LexA-box1 remained strong (**Figure [3](#F3){ref-type="fig"}**). For the DARS site, which has the LexA-box4 overlapping with DnaA-box5 and 6, the LexA protection was clear. While the overlap of the protection of the two proteins at the DARS site makes it difficult to determine whether LexA is still bound in the presence of DnaA, the appearance of the DnaA protections at the same concentration as in the absence of LexA suggests that the former can bind even in the presence of the latter and could thus displace it (**Figure [3](#F3){ref-type="fig"}**). These results suggest that LexA binds to LexA-box1 with high affinity even in the presence of high concentrations of DnaA but not to LexA-box2, 3, and 4. High concentrations of DnaA weaken the binding of LexA to its low affinity boxes. The competition of DnaA for its binding sites with LexA is not necessarily dependent on the fact that DnaA-boxes overlap with the LexA-boxes, possibly due to the ability of ATP-DnaA to form oligomeric structures.

![DnaA and LexA protect the *uvrB* promoter region in either competitive or independent manner. The *uvrB* promoter fragment (--513 to +12 relative to the transcription starting site of *uvrB*p1) was generated by PCR using the upstream oligonucleotide labeled with gamma ^32^p-ATP by T4 kinase at the 5′ end. The labeled DNA was either incubated at 37°C with increasing concentrations (50, 100, 200, 300, and 600 nM) of LexA (left) or ATP-DnaA (right) protein. After 10 min incubation of either the ATP-DnaA or the LexA protein with the labeled DNA, the sample had the other protein. The DNA was cleaved by DNase I for 20--30 s after 10 min of incubation with the second protein. The reaction was stopped by addition of an equal volume of formamide gel loading buffer and placed on ice. The gray boxes show the sites protected by the LexA protein. The white boxes correspond to the protection by ATP-DnaA. The protected DnaA-boxes are indicated as D, the LexA-boxes are as L. The DARS site is also shown. P1, P2, and P3 represent promoter *uvrB*p1, *uvrB*p2, *uvrB*p3, respectively. The right and left most two lanes are for ladder.](fmicb-09-01212-g003){#F3}

Strong protections at DARS1 were found for ATP-DnaA (**Figure [3](#F3){ref-type="fig"}**). The DnaA protections of these sites were concentration dependent and such protections were not found to be changed in the presence of LexA. To further understand how DnaA and LexA function in the control of *uvrB* gene expression, we investigated the interaction between DnaA and LexA. The bacterial two-hybrid analysis showed that DnaA did not interact directly with LexA (data not shown).

The Full Activity of the *uvrB* Promoter Region Requires Both the *uvrB*p1-2 and *uvrB*p3 Promoters
---------------------------------------------------------------------------------------------------

The *uvrB* promoter region has three characterized promoters, namely *uvrB*p1, *uvrB*p2, *uvrB*p3 ([@B43]), forming a cluster of *uvrB* promoters (**Figure [4A](#F4){ref-type="fig"}**). To determine the roles of these different promoters in the transcription control of the *uvrB* gene, each promoter was inserted in front of the *lacZ* gene into the MiniR1 plasmid. MiniR1 is a low copy plasmid, having 1--2 copies per the chromosomal *ter* site ([@B32]). The resultant plasmids carry a *uvrB*p1-3-*lacZ* (for short as R1-*uvrB*p1-3), *uvrB*p1-2-*lacZ* (R1-*uvrB*p1-2) or *uvrB*p3-*lacZ* (R1-*uvrB*p3) fusion as illustrated in **Figure [4A](#F4){ref-type="fig"}**. The R1-*uvrB*p1-3 construct includes all three promoters. Each plasmid was introduced into the wild-type MC4100 cells or the *dnaA*~A345S~, Δ*lexA*Δ*sulA* or Δ*lexA*Δ*sulA dnaA*~A345S~ derivatives (**Figure [4](#F4){ref-type="fig"}**). Promoter activity was then measured by the β-galactosidase activity assay in exponentially growing cells. Transcription from *uvrB*p1-2 accounted for 30% of the activity of the full-length promoter region while *uvrB*p3 accounted for 20% (**Figure [4B](#F4){ref-type="fig"}**). The results suggest that full activity of the *uvrB* promoter requires both the *uvrB*p1-2 and *uvrB*p3 promoters.

![The full activity of the *uvrB* promoter requires the *uvrB*p1-2 and *uvrB*p3 promoters. **(A)** Illustration for insertion of individual *uvrB* promoter in front of the *lacZ* gene into MiniR1 plasmid. Construction of the MiniR1-*uvrB*p1-3-*lacZ* (R1-*uvrB*p1-3), MiniR1-*uvrB*p1-2-*lacZ* (R1-*uvrB*p1-2) or MiniR1-*uvrB*p3-*lacZ* (R1-*uvrB*p3) plasmid was as mentioned in section "Materials and Methods." Promoter *uvrB*p1-2 contains promoter 1 and 2, ranging from --77 to +33; promoter *uvrB*p3 starts from --567 and ends at --280; Promoter *uvrB*p1-3 consists of promoter 1, 2, and 3, including the region from --567 to +33, the whole cluster of the *uvrB* promoters. The nucleotide positions are as indicated in **Figure [2](#F2){ref-type="fig"}**. The gray arrows represent the *lacZ* gene. The open rectangles represent LexA-boxes, the open triangles represent DnaA-boxes with orientation, the hatched rectangles represent LexA-boxes overlapping with DnaA-box. The filled arrows indicate positions of the promoters and orientation of transcriptions. The p1, p2, and p3 represent the *uvrB* promoter 1, 2, and 3. The wild-type, *dnaA*~A345S~, Δ*sulA*Δ*lexA* and Δ*sulA*Δ*lexA dnaA*~A345S~ cells were transformed by plasmid R1-*uvrB*p1-3, R1-*uvrB*p1-2, and R1-*uvrB*p3, respectively. The resultant transformants were exponentially grown in ABTGcasa medium at 37°C. Activity of the individual plasmid-borne *uvrB* promoter was measured as the β-galactosidase activity in the cells by Miller method ([@B30]). Activity of individual promoter relative to that of R1-*uvrB*p1-3 (229 U) in the wild-type cells is illustrated **(B)**. Relative activity of promoter R1-*uvrB*p1-2 **(C)**, or R1-*uvrB*p3 **(D)** in the *dnaA*~A345S~, Δ*sulA*Δ*lexA* and Δ*sulA*Δ*lexA dnaA*~A345S~ cells compared with that in the wild-type cells (70 U for *uvrB*p1-2 and 44 U for R1-*uvrB*p3) is illustrated. The insets indicate the relative activity of promoters in the Δ*sulA*Δ*lexA dnaA*~A345S~ cells against that in the Δ*sulA*Δ*lexA* cells. The values shown at top of the bars are the average of three individual experiments, and the standard errors are shown. ^∗∗∗^Stands for *P*-value ≤ 0.01, ^∗∗^for 0.01 \< *P*-value ≤ 0.05, and ns represents *P*-value \> 0.05.](fmicb-09-01212-g004){#F4}

Transcription From the Plasmid-Borne *uvrB*p1-2 or *uvrB*p3 Is Repressed by DnaA and LexA Independently
-------------------------------------------------------------------------------------------------------

To further clarify the function of DnaA and LexA in the control of the *uvrB*p1-2 or *uvrB*p3 promoter activity, transcription from the plasmid-borne *uvrB*p1-2-*lacZ* construct was measured in the *dnaA*~A345S~, Δ*sulA*Δ*lexA* and Δ*sulA*Δ*lexA dnaA*~A345S~ mutant strains as described above. As shown in **Figure [4C](#F4){ref-type="fig"}**, transcription in the *dnaA*~A345S~ or Δ*sulA*Δ*lexA* strains was about twofold higher relative to that in the wild-type cells. The transcription level further increased to 3.6-fold of wild type in the Δ*lexA*Δ*sulA dnaA*~A345S~ cells. The increase in transcription from *uvrB*p1-2 in the Δ*sulA*Δ*lexA dnaA*~A345S~ cells compared to that in the Δ*sulA*Δ*lexA* cells was clear (**Figure [4C](#F4){ref-type="fig"}** inset). These results suggest that *uvrB*p1-2 promoter activity is tightly regulated by both LexA and DnaA, consistent with the presence of LexA- and DnaA-boxes in the promoters. Similarly, transcription from the plasmid-borne *uvrB*p3 was twofold higher in the *dnaA*~A345S~ or Δ*sulA*Δ*lexA* cells compared with that in the wild-type cells, and a slight further increase was also found in the Δ*lexA*Δ*sulA dnaA*~A345S~ mutant (**Figure [4D](#F4){ref-type="fig"}**) although the increase was not significant (**Figure [4D](#F4){ref-type="fig"}** inset). The results indicate that both DnaA and LexA repress the *uvrB* expression and function independently.

Repression of the *uvrB*p3 Promoter Is Largely Dependent on the DnaA-Box6
-------------------------------------------------------------------------

The footprinting analysis showed that both DnaA and LexA bound to DnaA-box5, 6, 7 and LexA-box4 of the *uvrB*p3 promoter. To determine the role of such binding sites in the control of the *uvrB*p3 promoter, we mutated the TG in DnaA-box6 to CA on the *uvrB*p3 plasmid (a derivative of pTAC3953 as described in section "Materials and Methods") by site-directed mutagenesis, leading to the *uvrB*p3CA plasmid (**Figure [5A](#F5){ref-type="fig"}**). The mutations also changed the LexA-box4 since DnaA-box6 overlaps with LexA-box4 (**Figure [5A](#F5){ref-type="fig"}**) and destroyed the DARS1 site where ATP-DnaA is formed ([@B16]). It was found that transcription from *uvrB*p3CA was 5.9-fold higher relative to that from *uvrB*p3 in the wild-type cells (**Figure [5B](#F5){ref-type="fig"}**). Compared with *uvrB*p3, transcription from *uvrB*p3CA in the *dnaA*~A345S~ cells was 6.3-fold greater (**Figure [5B](#F5){ref-type="fig"}**), indicating that mutation of the site can still influence transcription in the absence of full DnaA activity, probably by influencing LexA binding. In the Δ*lexA*Δ*sulA* cells, transcription from *uvrB*p3CA was 13.4-fold higher relative to the activity of *uvrB*p3 (**Figure [5B](#F5){ref-type="fig"}**). Clearly, in the absence of LexA the mutation of the DnaA-box6 results in a dramatic change in transcription, suggesting that strong repression by the wild type ATP-DnaA is decreased due to the mutations. These same mutations can also impair ATP-DnaA regeneration activity at the DARS1, leading to a decrease in accumulation of ATP-DnaA compared with the wild type plasmid ([@B16]).

![DnaA-box6 in promoter *uvrB*p3 and LexA-box1 in *uvrB*p1-2 are important for control of the promoters. Mutations (TG to CA) in DnaA-box6 on plasmid *uvrB*p3 **(A)** and mutations (TG to GC) in LexA-box1 on plasmid *uvrB*p1-2 **(C)** were introduced, resulting in plasmid p*uvrB*p3CA-*lacZ* (indicated as *uvrB*p3CA for short) **(A)** and p*uvrB*p1-2GC-*lacZ* (as *uvrB*p1-2GC) **(C)**. The wild-type, *dnaA*~A345S~, Δ*sulA*Δ*lexA* and Δ*sulA*Δ*lexA dnaA*~A345S~ cells were transformed with plasmid *uvrB*p3CA and *uvrB*p1-2GC, respectively. Relative activity of the mutated promoter *uvrB*p3CA **(B)** or *uvrB*p1-2GC **(D)** in the wild-type and the mutant cells was compared with that of *uvrB*p3 or *uvrB*p1-2 after measurement of the β-galactosidase activity as mentioned in the legend to **Figure [2](#F2){ref-type="fig"}**. The open bars stand for *uvrB*p3 or *uvrB*p1-2, the filled bars for *uvrB*p3CA or *uvrB*p1-2GC. The values shown at top of the bars are the average of three individual experiments, and standard errors are shown. ^∗∗∗^Stands for *P*-value ≤ 0.01, ^∗∗^for 0.01 \< *P*-value ≤ 0.05, and ns represents *P*-value \> 0.05.](fmicb-09-01212-g005){#F5}

LexA-Box1 Is Important for Control of *uvrB*p1-2 Transcription
--------------------------------------------------------------

The *uvrB*p1-2 promoter contains LexA-box1 and DnaA-box1. LexA-box1 remains strongly protected by LexA in the presence of high concentrations of DnaA. To understand the role of LexA-box1 in the regulation of *uvrB*p1-2 transcription, we mutated TG to GC in LexA-box1, resulting in plasmid *uvrB*p1-2GC (**Figure [5C](#F5){ref-type="fig"}**). These mutations scrambled LexA-box1 since the conserved trimer CTG on the left of LexA-box1 is destroyed. Transcription from *uvrB*p1-2GC was about threefold higher of that from *uvrB*p1-2 in the wild-type cells (**Figure [5D](#F5){ref-type="fig"}**), indicating that LexA-box1 is important for the control of promoter activity. This result also suggests that binding of LexA to the mutated LexA-box1GC is weakened. However, transcription from *uvrB*p1-2GC did not change relative to that from *uvrB*p1-2 in the *dnaA*~A345S~, Δ*lexA*Δ*sulA* and Δ*lexA*Δ*sulA dnaA*~A345S~ cells (**Figure [5D](#F5){ref-type="fig"}**). The results indicate that the loss of repression in the mutant strains is thus the same in the presence or absence of the LexA-box1 mutation. This is expected in the case of the Δ*lexA*Δ*sulA* strain, however, it is surprising in the *dnaA*~A345S~ and Δ*lexA*Δ*sulA dnaA*~A345S~ cells since the LexA-box1 mutation should not influence binding by DnaA and a further increase in expression would be expected when DnaA is mutated. It is thus possible that this change in DNA sequence might also affect DnaA oligomerization or RNAP binding.

UV Irradiation Increases Transcription of the *uvrB* Gene
---------------------------------------------------------

We found that transcription of the chromosomal *uvrB* gene was increased 3.2-fold in the *uvrB-lacZ* strain after UV irradiation (**Figure [6A](#F6){ref-type="fig"}**) in the wild-type cells. The level of expression did not significantly change in the Δ*lexA*Δ*sulA* cells after UV irradiation (**Figure [6A](#F6){ref-type="fig"}**). These results confirm that the *uvrB* gene is one of the SOS genes which are regulated by the LexA protein ([@B19]), responding to UV-induced DNA damage. Interestingly, *uvrB* gene transcription increased less, 1.8-fold, in the *dnaA*~A345S~ cells indicating that DnaA's decreased repressor activity results in a decreased change in gene expression in the presence of LexA. This is not the case in the Δ*lexA*Δ*sulA dnaA*~A345S~ cells after UV treatment (**Figure [6A](#F6){ref-type="fig"}**), indicating that LexA is required for UV-dependent SOS induction but not DnaA. These results are consistent with the need of both DnaA and LexA to maintain a high level of repression in the absence of UV treatment.

![The simultaneous absence of LexA- and DnaA-repression leads to formation of elongated cells with incomplete replication and aberrant nucleoids. **(A)** Exponentially growing wild-type and mutant cells mentioned in the legend to **Figure [1A](#F1){ref-type="fig"}** except Δ*sulA* in ABTGcasa medium at 37°C were treated with UV (50 J/M^2^) at OD~450~ = 0.08. The expression of the *uvrB* gene was assayed as the β-galactosidase activity described in the legend to **Figure [1](#F1){ref-type="fig"}**. The filled bars represent expression after UV treatment relative to that from non-treated cells as indicated by the open bars. The values shown at top of the bars are the average of three individual experiments, and the standard errors are shown. ^∗∗∗^Stands for *P*-value ≤ 0.01, ^∗∗^for 0.01 \< *P*-value ≤ 0.05, and ns represents *P*-value \> 0.05. **(B)** Exponentially growing cells were treated for 4--5 generations with rifampicin and cephalexin to inhibit both initiation of replication and cell division but allowing ongoing replication finish. Then cells were analyzed by flow cytometer after staining with Hoechst 33258 for 30 min. The *X*-axis indicates chromosome equivalents per cell, the *Y*-axis represents the number of cells measured. Each measurement includes 10000 cells. The doubling time and genotype of the cells are shown. **(C)** Exponentially growing cells were harvested and fixed in 70% ethanol. Cells after staining in Hoechst 33258 for 30 min were visualized by Zeiss LSM710 confocal microscope as described in section "Materials and Methods." The blue structures indicate nucleoids and the red scale bar represents 2 μm.](fmicb-09-01212-g006){#F6}

The Simultaneous Absence of Both LexA- and DnaA-Dependent Repression on Transcription Results in Elongated Cells With Incomplete DNA Replication
------------------------------------------------------------------------------------------------------------------------------------------------

To clarify the role of DnaA-dependent repression on SOS-response genes and its link with DNA replication, we compared nucleoids and cell size in the *dnaA*~A345S~, Δ*lexA*Δ*sulA* and Δ*lexA*Δ*sulA dnaA*~A345S~ cells with that of the wild-type cells. Flow cytometry analysis showed that the wild-type cells had four or eight fully replicated chromosomes, after rifampicin and cephalexin treatment (**Figure [6B](#F6){ref-type="fig"}**). The DNA histogram of *dnaA*~A345S~ showed well-separated two-, three- and four-chromosome peaks (**Figure [6B](#F6){ref-type="fig"}**), indicating that the mutant cells contain fully replicated chromosomes although initiation of replication is asynchronous ([@B18]). However, the Δ*lexA*Δ*sulA* cell culture showed that a portion of the cells contained a DNA amount between four- and eight-chromosome after rifampicin and cephalexin treatment, indicating that a portion of Δ*lexA*Δ*sulA* cells has incomplete replication, probably due to overexpression of DNA repair proteins slowing down the replication forks (**Figure [6B](#F6){ref-type="fig"}**). The phenotype of incomplete replication was worsened in the Δ*lexA*Δ*sulA dnaA*~A345S~ cells. Some cells had only one-chromosome while other cells had more DNA than eight-chromosome equivalents (**Figure [6B](#F6){ref-type="fig"}**). These results underline the need for the wild-type DnaA to control both initiation of DNA replication and gene expression when the SOS response is activated. These results suggest that the Δ*lexA*Δ*sulA dnaA*~A345S~ cells have more serious DNA damage, even in the absence of UV irradiation, since severe incomplete replication can be caused from lack of replication elongation or/and partial degradation of the DNA ([@B46]; [@B33]).

Exponentially growing cells were fixed in 70% ethanol and visualized under Zeiss LSM710 Confocal microscope. As shown in **Figures [6B,C](#F6){ref-type="fig"}**, both the wild-type and Δ*lexA*Δ*sulA* cells were 2.4 ∼ 3.0 μm in length with a similar doubling time of 26 ∼ 27 min, containing mostly well-compacted one or two nucleoids. The *dnaA*~A345S~ cells were about 4.5 μm in length with a doubling time of 34 min and more nucleoids per cell. The Δ*lexA*Δ*sulA dnaA*~A345S~ cells were further elongated (about 5.5 μm) with a slower growth, and their multi-nucleoids were not well-compacted (**Figures [6B,C](#F6){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). These results together suggest that the simultaneous absence of both LexA- and DnaA-dependent repression of gene transcription results in production of elongated cells with incomplete replication of DNA, aberrant nucleoids and slower growth. It is likely that DnaA-dependent repression of gene transcription during the SOS response is required to prevent over-expression of the SOS regulon genes to maintain genome integrity.

Transcriptions of the *recN* and *dinJ* Genes Are Also Repressed by Both DnaA and LexA
--------------------------------------------------------------------------------------

To test whether DnaA is also involved in regulation of other SOS regulon genes ([@B15]; [@B41]), we searched for DnaA-box and LexA-box in the *dinJ* and *recN* genes and found that both genes had LexA-boxes and a DnaA-box around the transcription start sites as shown in Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}. We then inserted the *lacZ* reporter gene downstream of the chromosomal *recN* or *dinJ* genes, resulting in *recN-lacZ* or *dinJ-lacZ* derivatives of the MC4100 strain. The *recN-lacZ* or *dinJ-lacZ* allele was transferred to the *dnaA*~A345S~, Δ*lexA*Δ*sulA*, Δ*lexA*Δ*sulA dnaA*~A345S~ and *lexA*3 cells. As shown in **Figures [7A,B](#F7){ref-type="fig"}**, transcriptions of both the *recN* and *dinJ* genes were about 2 ∼ 3-fold higher in the *dnaA*~A345S~, Δ*lexA*Δ*sulA* and *lexA*3 *dnaA*~A345S~ cells, respectively, indicating that transcription of *recN* or *dinJ* is repressed by both DnaA and LexA, and that the DnaA- or LexA-dependent repression of gene expression is independent. As expected, the increase in transcription of *recN* or *dinJ* was strengthened in the Δ*lexA*Δ*sulA dnaA*~A345S~ cells and it was significant relative to that in the Δ*sulA*Δ*lexA* cells (**Figure [7](#F7){ref-type="fig"}** insets), suggesting that repression from DnaA and LexA is additive. The observation is supported by the presence of an overlapping LexA-box with a DnaA-box in the *recN* or *dinJ* promoter ([@B14]). We conclude that DnaA is, indeed, involved in control of other genes of the SOS regulon.

![The DnaA and LexA proteins reppress expression of the *recN* or *dinJ* gene independently. The wild-type, *dnaA*~A345S~, Δ*sulA*Δ*lexA*, Δ*sulA*Δ*lexA dnaA*~A345S~ and *lexA*3 *dnaA*~A345S~ cells carrying *recN*-*lacZ* **(A)** or *dinJ*-*lacZ* **(B)** fusion on their chromosomes were exponentially grown in ABTGcasa medium at 37°C. The β-galactosidase activity from *recN*-*lacZ* (13 U for wild-type) **(A)** or *dinJ*-*lacZ* (13 U for wild-type) **(B)** fusion in the cells was determined as described in the legend to **Figure [1](#F1){ref-type="fig"}**. The insets indicate the relative expression of *renN-lacZ* or *dinJ*-*lacZ* in the Δ*sulA* Δ*lexA dnaA~A345S~* cells against that in the Δ*sulA*Δ*lexA* cells. The values shown at top of the bars are the average of three individual experiments, and the standard errors are shown. ^∗∗∗^Stands *P*-value ≤ 0.01, ^∗∗^ for 0.01 \< *P*-value ≤ 0.05, ns represents *P*-value \> 0.05.](fmicb-09-01212-g007){#F7}

Discussion
==========

The UvrB protein is a very important protein in the response to DNA damage in prokaryotic cells, performing NER with UvrA and UvrC ([@B50]). UvrB paralogs have been found in all organisms ([@B42]) and the NER repair system plays a central role in maintaining genome integrity. Defects in NER cause several lines of diseases in humans including skin cancers ([@B24]). However, the control mechanism of *uvrB* gene expression remains elusive. The results presented here show that the DNA replication initiator, the DnaA protein, and the SOS regulator LexA, regulate the expression of the *uvrB* gene by interacting with the *uvrB* promoter region. The regulation mode by both DnaA and LexA applies to the expression control of several SOS genes, and may be conserved in Gram-negative bacteria. However, this hypothesis requires further experiments to be confirmed.

DnaA and LexA Regulate Transcription of the *uvrB* Gene By Binding to Their Specific Sites
------------------------------------------------------------------------------------------

We have shown that transcription from the *uvrB* promoters is repressed by the presence of both the wild-type LexA and DnaA proteins (**Figure [1A](#F1){ref-type="fig"}**). The full activity of the *uvrB* promoter cluster requires both *uvrB*p1-2 and *uvrB*p3 promoters and is repressed by both DnaA and LexA in an additive manner (**Figures [4B](#F4){ref-type="fig"}--[D](#F4){ref-type="fig"}**). The DNase I footprinting experiments show that both proteins bind to the promoter region and that LexA-box1 in *uvrBp*1-2 is the strongest LexA-box from which LexA is not easily displaced by increasing amounts of ATP-DnaA, unlike what is observed at the other LexA-box in this region (**Figure [3](#F3){ref-type="fig"}**). LexA-box1 has a typical consensus sequence containing both CTG and CAG trimers at the two ends ([@B54]; [@B14]; [@B53]) while LexA-box2, 3, and 4 do not. Mutations of LexA-box1 and DnaA-box6 in fact show a strong effect on promoter activity *in vivo* (**Figure [5](#F5){ref-type="fig"}**). The results indicate that binding of LexA or DnaA to LexA-boxes or DnaA-boxes in the *uvrB* promoter region results in a direct control of promoter activity.

The *uvrB*p3 promoter is interesting because it completely overlaps with the DARS1 sequence. While the DARS1 sequence is not essential, in its absence initiation of DNA replication occurs at an increased cell mass ([@B16]). Binding of LexA to DARS1 and RNA polymerase to the *uvrB*p3 promoter could both compete with DnaA binding and thus interfere with the regeneration of ATP-DnaA both in the absence (intact LexA) and the presence (RNAP binding) of the SOS response. This can explain the increased loss of repression by the DnaA-box6 mutation in the Δ*lexA*Δ*sulA* strain (**Figure [5B](#F5){ref-type="fig"}**).

DnaA and LexA May Coordinate DNA Replication With DNA Repair
------------------------------------------------------------

LexA-dependent regulation of DARS1 activity is only one of several processes resulting in an increased ATP-DnaA to ADP-DnaA ratio following DNA damage. Upon prolonged stress, fork stalling and blockage of DNA replication, ATP-DnaA accumulates in the cell ([@B23]). Hydrolysis of the ATP bound to DnaA is mediated by the RIDA process, which requires ongoing DNA replication ([@B20]). When the DNA replication forks stall in the presence of DNA damage ATP-DnaA can thus accumulate in the cell and bind to the other sites on the genome. The longer DNA replication has been stalled, the more ATP-DnaA has accumulated in the cell. This would ensure that the expression of DNA repair proteins by the SOS response is limited when the DNA replication forks have stalled and there is less DNA per cell. Furthermore, expression of the *dnaA* gene is induced by DNA damage in a RecA and LexA-dependent manner despite the absence of a LexA-box at the *dnaA* promoter region ([@B38]). In these conditions SeqA has been shown to play a key role in cell survival, possibly by limiting over-initiation of DNA replication by increased amounts of ATP-DnaA in the presence of stalled replication forks ([@B49]). The increase in ATP-DnaA by decreased RIDA, increased gene expression and increased DARS1 activity occur at the same time as loss of repression by LexA. This may appear to be inconsistent, since they both repress gene expression at several shared targets. However, it is possible that upon DNA damage LexA cleavage results in a rapid loss of repression while the increase in ATP-DnaA occurs with a time delay, due in part to protein synthesis, resulting in a pulse of transcription activity, which, however, is proportional to the number of replication forks, due the amount of ATP-DnaA-dependent repression observed in the absence of DNA damage. It appears to be a situation similar to the hyperinitiation stress observed during oxidative damage ([@B9]), but as a sensible response to the problem.

DnaA-Dependent Transcription Repression During the SOS Response Is Required for Maintaining Genome Integrity: A Model for Control of the SOS Regulon by LexA and DnaA
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

As a summary, we propose a model for the control of the SOS regulon by DnaA and LexA (**Figure [8](#F8){ref-type="fig"}**). Both DnaA and LexA repress expression of the SOS genes when the SOS response is off. When the SOS response is triggered due to DNA damage, LexA is self-cleaved ([@B25]), consequently LexA-repression is removed to derepress expression of the SOS genes to repair the DNA damage ([@B43]). During the SOS response, DnaA-dependent repression still works and largely limits the expression of the SOS genes, resulting in cells with normal nucleoids and growth rate but minor incomplete replication. The latter can be the indication of the DNA repair process since it includes controlled nicking and digestions of the DNA. The simultaneous absence of DnaA- and LexA-repression leads to cell elongation with serious incomplete replication, uncompacted nucleoids and slow growth (**Figures [6B,C](#F6){ref-type="fig"}**), possibly as a result of a further increase in expression of SOS dependent genes (**Figures [1A](#F1){ref-type="fig"}**, **[7A,B](#F7){ref-type="fig"}**). Obviously, the high level expression of the SOS genes is harmful, causing physiological problems in different cell processes. Among these problems, incomplete DNA replication can be caused by either lack of replication elongation or partial degradation of the DNA ([@B46]; [@B33]) as a result of DNA damage. It is reasonable to consider that an excess of DNA repair proteins might "repair" DNA regions where the repairs are unwanted, resulting in DNA damage. Indeed, for example overproduction of DinB has been shown to be lethal ([@B27]). It is likely that DnaA-dependent repression of the transcription of SOS genes during the SOS response is required to prevent over-expression of the SOS genes to maintain genome integrity.

![A model for control of the SOS regulon by DnaA and LexA. In the proposed model, both DnaA and LexA repress expression of the SOS genes when SOS is off. When SOS is on, LexA is self-cleaved, but DnaA-repression still works, leading to partial expression of the SOS genes and consequent cells with normal nucleoids and growth. In the simultaneous absence of LexA- and DnaA-repression, the SOS genes are mostly derepressed, forming elongated cells with incomplete replication, aberrant nucleoids and slow growth. The red ovals represent the DnaA protein, the cyan triangles represent the LexA protein, the pink oval represents the DnaA~A345S~ mutant protein, arrows indicate orientation of transcriptions of the SOS gene or LexA cleavage and removal as indicated.](fmicb-09-01212-g008){#F8}

Interestingly, 13 DnaA-boxes are found in potential LexA-boxes on the *E. coli* chromosomes ([@B14]). In further analysis, the overlapping LexA-box with a DnaA-box in the *uvrB* or *recN* promoter was found in several Gram-negative bacteria including *Salmonella typhimurium*, *Serratia marcescens*, *Citrobacter rodentium*, *Klebsiella pneumoniae* and *Yersinia enterocolitica* (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). These results suggest that DnaA is likely involved in regulation of the SOS regulon, reducing expression of the SOS genes during the SOS response in a manner that is coupled with DNA replication. The control mode may be conserved within Gram-negative bacteria.
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ADP/ATP-DnaA

:   ADP or ATP binds DnaA

*bla*, ampicillin resistance gene, *cat*, chloramphenicol resistance gene, DARS

:   DnaA reactivation site

DnaA-box

:   DnaA binding site

FRT

:   FLP recognition target

LexA-box

:   LexA binding site

*neo*, kanamycin resistance gene, NER

:   nucleotide excision repair

RIDA

:   regulatory inactivation of DnaA

ssDNA

:   single strand DNA

*tet*

:   tetracycline resistant gene.
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